Share:
Share this content in WeChat
X
Review
Magnetic resonance imaging research progress of effective brain network connectivity in patients with major depressive disorder
SUN Jinnan  YI Wei  HUANG Junlin  REN Rui 

Cite this article as: SUN J N, YI W, HUANG J L, et al. Magnetic resonance imaging research progress of effective brain network connectivity in patients with major depressive disorder[J]. Chin J Magn Reson Imaging, 2024, 15(11): 153-159. DOI:10.12015/issn.1674-8034.2024.11.024.


[Abstract] Major depressive disorder (MDD) is a kind of mental disorder characterized by persistent sadness, lack of energy, low mood, abnormal sleep, slow thinking and so on. As a research method that can reveal the causal relationship between brain regions, effective connection (EC) plays an important role in the study of MDD. This article reviews the EC analysis methods, the research of EC in different brain networks and important brain regions of MDD, and the changes of EC after clinical treatment, in order to further reveal the pathogenesis of MDD and provide reference and technical support for the research of therapeutic targets.
[Keywords] major depressive disorder;effective connection;magnetic resonance imaging;drug therapy;repetitive transcranial magnetic stimulation;electroconvulsive therapy;deep brain stimulation

SUN Jinnan1   YI Wei1   HUANG Junlin1   REN Rui2*  

1 School of Medical Imaging, Binzhou Medical University, Yantai264003, China

2 Department of Radiology, Binzhou Medical University Hospital, BinZhou256603, China

Corresponding author: REN R, E-mail: 865699206@qq.com

Conflicts of interest   None.

Received  2024-07-05
Accepted  2024-11-08
DOI: 10.12015/issn.1674-8034.2024.11.024
Cite this article as: SUN J N, YI W, HUANG J L, et al. Magnetic resonance imaging research progress of effective brain network connectivity in patients with major depressive disorder[J]. Chin J Magn Reson Imaging, 2024, 15(11): 153-159. DOI:10.12015/issn.1674-8034.2024.11.024.

[1]
LI H, JIANG Z D, LI X L. Research progress of multimodal MRI in evaluating the rapid antidepressant effect of ketamine[J]. Chin J Magn Reson Imag, 2023, 14(4): 115-119. DOI: 10.12015/issn.1674-8034.2023.04.020.
[2]
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
[3]
LU J, XU X F, HUANG Y Q, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2021, 8(11): 981-990. DOI: 10.1016/S2215-0366(21)00251-0.
[4]
WANG J, LI B J, LIU J, et al. Large-scale effective connectivity analysis reveals the existence of two mutual inhibitory systems in patients with major depression[J/OL]. Neuroimage Clin, 2024, 41: 103556 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38134741/. DOI: 10.1016/j.nicl.2023.103556.
[5]
WILLINGER D, HÄBERLING I, ILIOSKA I, et al. Weakened effective connectivity between salience network and default mode network during resting state in adolescent depression[J/OL]. Front Psychiatry, 2024, 15: 1386984 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38638415/. DOI: 10.3389/fpsyt.2024.1386984.
[6]
KANDILAROVA S, STOYANOV D, ARYUTOVA K, et al. Effective connectivity between the orbitofrontal cortex and the precuneus differentiates major psychiatric disorders: results from a transdiagnostic spectral DCM study[J]. CNS Neurol Disord Drug Targets, 2023, 22(2): 180-190. DOI: 10.2174/1871527320666210917142815.
[7]
MIRJEBREILI S M, SHALBAF R, SHALBAF A. Prediction of treatment response in major depressive disorder using a hybrid of convolutional recurrent deep neural networks and effective connectivity based on EEG signal[J]. Phys Eng Sci Med, 2024, 47(2): 633-642. DOI: 10.1007/s13246-024-01392-2.
[8]
DAI P S, ZHOU X Y, XIONG T, et al. Altered effective connectivity among the cerebellum and Cerebrum in patients with major depressive disorder using multisite resting-state fMRI[J]. Cerebellum, 2023, 22(5): 781-789. DOI: 10.1007/s12311-022-01454-9.
[9]
HAINES N, SULLIVAN-TOOLE H, OLINO T. From classical methods to generative models: tackling the unreliability of neuroscientific measures in mental health research[J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2023, 8(8): 822-831. DOI: 10.1016/j.bpsc.2023.01.001.
[10]
ZHENG L J, YANG G F, ZHANG X Y, et al. Altered amygdala and hippocampus effective connectivity in mild cognitive impairment patients with depression: a resting-state functional MR imaging study with granger causality analysis[J]. Oncotarget, 2017, 8(15): 25021-25031. DOI: 10.18632/oncotarget.15335.
[11]
FRISTON K J, HARRISON L, PENNY W. Dynamic causal modelling[J]. NeuroImage, 2003, 19(4): 1273-1302. DOI: 10.1016/s1053-8119(03)00202-7.
[12]
WANG Y, ZHOU J J, CHEN X Y, et al. Effects of escitalopram therapy on effective connectivity among core brain networks in major depressive disorder[J/OL]. J Affect Disord, 2024, 350: 39-48 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38220106/. DOI: 10.1016/j.jad.2024.01.115.
[13]
FRISTON K J, KAHAN J, BISWAL B, et al. A DCM for resting state fMRI[J]. NeuroImage, 2014, 94(100): 396-407. DOI: 10.1016/j.neuroimage.2013.12.009.
[14]
LIU J Y, YANG W X, MA Y L, et al. Effective hyper-connectivity network construction and learning: application to major depressive disorder identification[J/OL]. Comput Biol Med, 2024, 171: 108069 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38394798/. DOI: 10.1016/j.compbiomed.2024.108069.
[15]
MENON V. Large-scale brain networks and psychopathology: a unifying triple network model[J]. Trends Cogn Sci, 2011, 15(10): 483-506. DOI: 10.1016/j.tics.2011.08.003.
[16]
LI Y, QIAN L Z, LI G, et al. Frequency specificity of aberrant triple networks in major depressive disorder: a resting-state effective connectivity study[J/OL]. Front Neurosci, 2023, 17: 1200029 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/37457005/. DOI: 10.3389/fnins.2023.1200029.
[17]
DEMASTER D, GODLEWSKA B R, LIANG M R, et al. Effective connectivity between resting-state networks in depression[J/OL]. J Affect Disord, 2022, 307: 79-86 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/35331822/. DOI: 10.1016/j.jad.2022.03.041.
[18]
COSÍO-GUIRADO R, SORIANO-MAS C, DEL CERRO I, et al. Diagnosis of late-life depression using structural equation modeling and dynamic effective connectivity during resting fMRI[J/OL]. J Affect Disord, 2022, 318: 246-254 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/36096369/. DOI: 10.1016/j.jad.2022.09.010.
[19]
LI G S, LIU Y J, ZHENG Y T, et al. Large-scale dynamic causal modeling of major depressive disorder based on resting-state functional magnetic resonance imaging[J]. Hum Brain Mapp, 2020, 41(4): 865-881. DOI: 10.1002/hbm.24845.
[20]
KENNIS M, GERRITSEN L, VAN DALEN M, et al. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis[J]. Mol Psychiatry, 2020, 25(2): 321-338. DOI: 10.1038/s41380-019-0585-z.
[21]
ZHONG X, YAO S Q, CHENG C, et al. Study on effective connectivity in major depressive disorder patients under psychosocial stress task[J]. Chin J Clin Psychol, 2023, 31(1): 16-21. DOI: 10.16128/j.cnki.1005-3611.2023.01.003.
[22]
KANDILAROVA S, STOYANOV D, KOSTIANEV S, et al. Altered resting state effective connectivity of anterior Insula in depression[J/OL]. Front Psychiatry, 2018, 9: 83 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/29599728/. DOI: 10.3389/fpsyt.2018.00083.
[23]
HAO Z Y, LI H H, LIN Y X. Pain avoidance and effective connectivity between dlPFC and insula in suicide attempters with major depressive disorder[J]. Acta Psychol Sin, 2023, 55(12): 1966-1978. DOI: 10.3724/SP.J.1041.2023.01966.
[24]
LIU Y W, XIA S Y, REN Q F, et al. Research progress of magnetic resonance imaging in amygdala of major depressive disorder[J]. Chin J Magn Reson Imag, 2024, 15(4): 177-181, 213. DOI: 10.12015/issn.1674-8034.2024.04.029.
[25]
LI W C, WANG C Y, LAN X F, et al. Resting-state functional connectivity of the amygdala in major depressive disorder with suicidal ideation[J/OL]. J Psychiatr Res, 2022, 153: 189-196 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/35839660/. DOI: 10.1016/j.jpsychires.2022.07.001.
[26]
JAMIESON A J, LEONARDS C A, DAVEY C G, et al. Major depressive disorder associated alterations in the effective connectivity of the face processing network: a systematic review[J/OL]. Transl Psychiatry, 2024, 14(1): 62 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38272868/. DOI: 10.1038/s41398-024-02734-0.
[27]
BERBOTH S, MORAWETZ C. Amygdala-prefrontal connectivity during emotion regulation: a meta-analysis of psychophysiological interactions[J/OL]. Neuropsychologia, 2021, 153: 107767 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/33516732/. DOI: 10.1016/j.neuropsychologia.2021.107767.
[28]
SACU, WACKERHAGEN C, ERK S, et al. Effective connectivity during face processing in major depression-distinguishing markers of pathology, risk, and resilience[J]. Psychol Med, 2023, 53(9): 4139-4151. DOI: 10.1017/S0033291722000824.
[29]
JAMIESON A J, HARRISON B J, DAVEY C G. Altered effective connectivity of the extended face processing system in depression and its association with treatment response: findings from the YoDA-C randomized controlled trial[J]. Psychol Med, 2021, 51(16): 2933-2944. DOI: 10.1017/S0033291721002567.
[30]
SHENG F R, WANG Y, LI R N, et al. Altered effective connectivity among face-processing systems in major depressive disorder[J/OL]. J Psychiatry Neurosci, 2024, 49(3): E145-E156 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38692692/. DOI: 10.1503/jpn.230123.
[31]
XIAO Y, ZHAO L, WANG D L, et al. Effective connectivity of right amygdala subregions predicts symptom improvement following 12-week pharmacological therapy in major depressive disorder[J/OL]. Front Neurosci, 2021, 15: 742102 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/34588954/. DOI: 10.3389/fnins.2021.742102.
[32]
RUPPRECHTER S, ROMANIUK L, SERIES P, et al. Blunted medial prefrontal cortico-limbic reward-related effective connectivity and depression[J]. Brain, 2020, 143(6): 1946-1956. DOI: 10.1093/brain/awaa106.
[33]
ZHU Y, HUANG T M, LI R L, et al. Distinct resting-state effective connectivity of large-scale networks in first-episode and recurrent major depression disorder: evidence from the REST-meta-MDD consortium[J/OL]. Front Neurosci, 2023, 17: 1308551 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/38148946/. DOI: 10.3389/fnins.2023.1308551.
[34]
RAY D, BEZMATERNYKH D, MEL'NIKOV M, et al. Altered effective connectivity in sensorimotor cortices is a signature of severity and clinical course in depression[J/OL]. Proc Natl Acad Sci U S A, 2021, 118(40): e2105730118 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/34593640/. DOI: 10.1073/pnas.2105730118.
[35]
ROLLS E T, CHENG W, GILSON M, et al. Effective connectivity in depression[J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2018, 3(2): 187-197. DOI: 10.1016/j.bpsc.2017.10.004.
[36]
TAK S, LEE S, PARK C A, et al. Altered effective connectivity within the Fronto-limbic circuitry in response to negative emotional task in female patients with major depressive disorder[J]. Brain Connect, 2021, 11(4): 264-277. DOI: 10.1089/brain.2020.0859.
[37]
XU R, HUANG X B. Progress of non-pharmacological treatments for treatment-resistant depression[J]. J Pract Med, 2024, 40(4): 439-446. DOI: 10.3969/j.issn.1006-5725.2024.04.001.
[38]
KISHI T, IKUTA T, SAKUMA K, et al. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis[J]. Mol Psychiatry, 2023, 28(1): 402-409. DOI: 10.1038/s41380-022-01824-z.
[39]
ENNEKING V, LEEHR E J, DANNLOWSKI U, et al. Brain structural effects of treatments for depression and biomarkers of response: a systematic review of neuroimaging studies[J]. Psychol Med, 2020, 50(2): 187-209. DOI: 10.1017/S0033291719003660.
[40]
ZHANG S D, ZHOU J J, CUI J, et al. Effects of 12-week escitalopram treatment on resting-state functional connectivity of large-scale brain networks in major depressive disorder[J]. Hum Brain Mapp, 2023, 44(6): 2572-2584. DOI: 10.1002/hbm.26231.
[41]
ALEXANDER L, JELEN L A, MEHTA M A, et al. The anterior cingulate cortex as a key locus of ketamine's antidepressant action[J/OL]. Neurosci Biobehav Rev, 2021, 127: 531-554 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/33984391/. DOI: 10.1016/j.neubiorev.2021.05.003.
[42]
CUI J, WANG Y, LIU R, et al. Effects of escitalopram therapy on resting-state functional connectivity of subsystems of the default mode network in unmedicated patients with major depressive disorder[J/OL]. Transl Psychiatry, 2021, 11(1): 634 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/34903712/. DOI: 10.1038/s41398-021-01754-4.
[43]
KUNG P H, DAVEY C G, HARRISON B J, et al. Frontoamygdalar effective connectivity in youth depression and treatment response[J]. Biol Psychiatry, 2023, 94(12): 959-968. DOI: 10.1016/j.biopsych.2023.06.009.
[44]
LUO X, ZHANG B. Advances in the application of magnetic resonance imaging in the localization of therapeutic targets for transcranial magnetic stimulation in depression[J]. Chin J Magn Reson Imag, 2023, 14(11): 150-154. DOI: 10.12015/issn.1674-8034.2023.11.025.
[45]
HADAS I, SUN Y M, LIOUMIS P, et al. Association of repetitive transcranial magnetic stimulation treatment with subgenual cingulate hyperactivity in patients with major depressive disorder: a secondary analysis of a randomized clinical trial[J/OL]. JAMA Netw Open, 2019, 2(6): e195578 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/31167023/. DOI: 10.1001/jamanetworkopen.2019.5578.
[46]
IWABUCHI S J, AUER D P, LANKAPPA S T, et al. Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression[J]. Eur Neuropsychopharmacol, 2019, 29(5): 681-690. DOI: 10.1016/j.euroneuro.2019.02.012.
[47]
HAN S Z, LI X X, WEI S C, et al. Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: a randomized double-blind trial and TMS-EEG study[J/OL]. Cell Rep Med, 2023, 4(6): 101060 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/37263267/. DOI: 10.1016/j.xcrm.2023.101060.
[48]
YANG X, DONG Z Q, WANG Y, et al. Advances in the etiology and clinical treatment of depression[J]. Sci Sin Vitae, 2022, 52(11): 1678-1691. DOI: 10.1360/SSV-2022-0157.
[49]
XU J P, WANG J J, BAI T J, et al. Electroconvulsive therapy induces cortical morphological alterations in major depressive disorder revealed with surface-based morphometry analysis[J/OL]. Int J Neural Syst, 2019, 29(7): 1950005 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/31387489/. DOI: 10.1142/S0129065719500059.
[50]
DOESSCHATE F TEN, BRUIN W, ZEIDMAN P, et al. Effective resting-state connectivity in severe unipolar depression before and after electroconvulsive therapy[J]. Brain Stimul, 2023, 16(4): 1128-1134. DOI: 10.1016/j.brs.2023.07.054.
[51]
WANG J J, WEI Q, BAI T J, et al. Electroconvulsive therapy selectively enhanced feedforward connectivity from fusiform face area to amygdala in major depressive disorder[J]. Soc Cogn Affect Neurosci, 2017, 12(12): 1983-1992. DOI: 10.1093/scan/nsx100.
[52]
WEI Q, JI Y, BAI T J, et al. Enhanced cerebro-cerebellar functional connectivity reverses cognitive impairment following electroconvulsive therapy in major depressive disorder[J]. Brain Imaging Behav, 2021, 15(2): 798-806. DOI: 10.1007/s11682-020-00290-x.
[53]
AMIRI S, ARBABI M, RAHIMI M, et al. Effective connectivity between deep brain stimulation targets in individuals with treatment-resistant depression[J/OL]. Brain Commun, 2023, 5(5): fcad256 [2024-07-04]. https://pubmed.ncbi.nlm.nih.gov/37901039/. DOI: 10.1093/braincomms/fcad256.
[54]
BURKE M J, ROMANELLA S M, MENCARELLI L, et al. Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms[J]. Mol Psychiatry, 2022, 27(3): 1658-1666. DOI: 10.1038/s41380-021-01397-3.

PREV Advances in behavior and imaging studies of cognitive flexibility changes in neurodegenerative disease
NEXT The progress of brain structural and functional magnetic resonance imaging in patients with obstructive sleep apnea
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn